4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: July 25, 2019
Period of Report: July 16, 2019
Accession Number: 0001645470-19-000043

View Document ↗ View on SEC.gov ↗